Veronica Setiawan, PhD
Population and Public Health Sciences
Dr. V. Wendy Setiawan is Professor of Population & Public Health Sciences and Professor of Medicine at USC, Co-Leader of the Cancer Epidemiology Program in the Norris Comprehensive Cancer Center and the Associate Director for Population Sciences in the USC Research Center for Liver Diseases. She is a cancer epidemiologist focusing on understanding the determinants of ethnic differences in cancer incidence and mortality and identifying populations at highest risk because of genetic and biologic factors, environmental exposures, or a combination of both. Her research goal is to identify effective modalities for disease prevention for population at risk and ultimately reduce cancer health disparities. Her primary research interest in cancer study is focused on liver, pancreatic and endometrial cancer.
Dr. Setiawan received her BS in Biochemistry from UCLA, MS and PhD in Epidemiology from UCLA School of Public Health and completed her postdoctoral fellowship in Cancer and Genetic Epidemiology at Harvard and USC. Dr. Setiawan has been leading many projects in large epidemiologic studies including the Multiethnic Cohort Study and the NCI Epidemiology of Endometrial Cancer Consortium (E2C2), and the NHGRI Population Architecture Using Genomics and Epidemiology (PAGE) study. She received an NCI's career development award (K07) early in her career, and she is currently Principal Investigator of four active NCI and NIMHD-funded R01s and co-investigator of multiple NIH grants. Her studies utilize multi-level data integration encompassing genetics, biomarkers, lifestyle, and social/contextual factors to elucidate factors associated with differences in cancer incidence and outcome across racial/ethnic groups. She has published over 150 peer-reviewed papers as well as book chapters and review articles. She serves on the editorial boards of the Journal of National Cancer Institute, Cancer Epidemiology, Biomarkers and Prevention, and Cancer Causes and Control. She is also a standing member of the NIH/NCI Career Development K award study section.
Rising incidence and racial disparities of early-onset pancreatic cancer in the United States, 1995-2018.
Gastroenterology. 2022 Mar 11;. doi: 10.1053/j.gastro.2022.03.011. Epub 2022 Mar 11. PubMed PMID: 35288111;
Traffic-Related Air Pollution and Lung Cancer Incidence: The California Multiethnic Cohort Study.
Am J Respir Crit Care Med. 2022 Jun 1;. doi: 10.1164/rccm.202107-1770OC. Epub 2022 Jun 1. PubMed PMID: 35649154;
Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3).
Int J Epidemiol. 2022 Jun 13;51(3):e73-e86. doi: 10.1093/ije/dyab211. PubMed PMID: 34652432;
Race differences in the associations between menstrual cycle characteristics and epithelial ovarian cancer.
Cancer Epidemiol Biomarkers Prev. 2022 Jun 2;. doi: 10.1158/1055-9965.EPI-22-0115. Epub 2022 Jun 2. PubMed PMID: 35654411;
Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017-2018.
Hepatol Commun. 2022 May 9;. doi: 10.1002/hep4.1981. Epub 2022 May 9. PubMed PMID: 35527706;
- Cancer Epidemiology
- Cancer Epidemiology
- Principles of Epidemiology